|
1
|
Ying WZ, Lin SY and Qiu CL: Study of
permeability of the glomerular capillary wall in human membranous
nephropathy. Zhonghua Nei Ke Za Zhi. 25:227–231. 2541986.In
Chinese.
|
|
2
|
Satchell SC and Braet F: Glomerular
endothelial cell fenestrations: an integral component of the
glomerular filtration barrier. Am J Physiol Renal Physiol.
296:F947–F956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Myers BD: Pathophysiology of proteinuria
in diabetic glomerular disease. J Hypertens Suppl. 8:S41–S46. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Remuzzi G and Bertani T: Is
glomerulosclerosis a consequence of altered glomerular permeability
to macromolecules? Kidney Int. 38:384–394. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schnoor M, Lai FP, Zarbock A, et al:
Cortactin deficiency is associated with reduced neutrophil
recruitment but increased vascular permeability in vivo. J Exp Med.
208:1721–1735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Romero IA, Radewicz K, Jubin E, Michel CC,
Greenwood J, Couraud PO and Adamson P: Changes in cytoskeletal and
tight junctional proteins correlate with decreased permeability
induced by dexamethasone in cultured rat brain endothelial cells.
Neurosci Lett. 344:112–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dudek SM and Garcia JG: Cytoskeletal
regulation of pulmonary vascular permeability. J Appl Physiol
(1985). 91:1487–1500. 2001.
|
|
8
|
Spindler V, Peter D, Harms GS, Asan E and
Waschke J: Ultrastructural analysis reveals cAMP-dependent
enhancement of microvascular endothelial barrier functions via
Rac1-mediated reorganization of intercellular junctions. Am J
Pathol. 178:2424–2436. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng H, Wang C, Ye ZC, et al: How
increased VEGF induces glomerular hyperpermeability: a potential
signaling pathway of Rac1 activation. Acta Diabetol. 47(Suppl 1):
57–63. 2010. View Article : Google Scholar
|
|
10
|
Spindler V, Schlegel N and Waschke J: Role
of GTPases in control of microvascular permeability. Cardiovasc
Res. 87:243–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Semina EV, Rubina KA, Rutkevich PN,
Voyno-Yasenetskaya TA, Parfyonova YV and Tkachuk VA: T-cadherin
activates Rac1 and Cdc42 and changes endothelial permeability.
Biochemistry (Mosc). 74:362–370. 2009. View Article : Google Scholar
|
|
12
|
Mehta D and Malik AB: Signaling mechanisms
regulating endothelial permeability. Physiol Rev. 86:279–367. 2006.
View Article : Google Scholar
|
|
13
|
Guo X, Wang L, Chen B, et al: ERM protein
moesin is phosphorylated by advanced glycation end products and
modulates endothelial permeability. Am J Physiol Heart Circ
Physiol. 297:H238–H246. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo XH, Huang QB, Chen B, et al: Advanced
glycation end products induce actin rearrangement and subsequent
hyperpermeability of endothelial cells. APMIS. 114:874–883. 2006.
View Article : Google Scholar
|
|
15
|
Guo XH, Huang QB, Chen B, Wang SY, Hou FF
and Fu N: Mechanism of advanced glycation end products-induced
hyperpermeability in endothelial cells. Sheng Li Xue Bao.
57:205–210. 2005.In Chinese. PubMed/NCBI
|
|
16
|
Sheikpranbabu S, Haribalaganesh R, Lee KJ
and Gurunathan S: Pigment epithelium-derived factor inhibits
advanced glycation end products-induced retinal vascular
permeability. Biochimie. 92:1040–1051. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akis N and Madaio MP: Isolation, culture,
and characterization of endothelial cells from mouse glomeruli.
Kidney Int. 65:2223–2227. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rops AL, van der Vlag J, Jacobs CW, et al:
Isolation and characterization of conditionally immortalized mouse
glomerular endothelial cell lines. Kidney Int. 66:2193–2201. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Laulajainen T, Julkunen I, Haltia A,
Knuutila S, Miettinen A and Holthöfer H: Establishment and
characterization of a rat glomerular endothelial cell line. Lab
Invest. 69:183–192. 1993.PubMed/NCBI
|
|
20
|
Glomb MA and Monnier VM: Mechanism of
protein modification by glyoxal and glycolaldehyde, reactive
intermediates of the Maillard reaction. J Biol Chem.
270:10017–10026. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagai R, Unno Y, Hayashi MC, Masuda S,
Hayase F, Kinae N and Horiuchi S: Peroxynitrite induces formation
of N(epsilon)-(carboxymethyl) lysine by the cleavage of Amadori
product and generation of glucosone and glyoxal from glucose: novel
pathways for protein modification by peroxynitrite. Diabetes.
51:2833–2839. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou FF, Boyce J, Chertow GM, Kay J and
Owen WF Jr: Aminoguanidine inhibits advanced glycation end products
formation on beta2-microglobulin. J Am Soc Nephrol. 9:277–283.
1998.PubMed/NCBI
|
|
23
|
Hou FF, Miyata T, Boyce J, et al:
beta(2)-Microglobulin modified with advanced glycation end products
delays monocyte apoptosis. Kidney Int. 59:990–1002. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eiselein L, Wilson DW, Lamé MW and
Rutledge JC: Lipolysis products from triglyceride-rich lipoproteins
increase endothelial permeability, perturb zonula occludens-1 and
F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol.
292:H2745–H2753. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng HZ, Zhao KS, Zhou BY and Huang QB:
Role of Rho kinase and actin filament in the increased vascular
permeability of skin venules in rats after scalding. Burns.
29:820–827. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu H and Parsons JT: Cortactin, an
80/85-kilodalton pp60src substrate, is a filamentous actin-binding
protein enriched in the cell cortex. J Cell Biol. 120:1417–1426.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paradis H, Islam T, Tucker S, Tao L, Koubi
S and Gendron RL: Tubedown associates with cortactin and controls
permeability of retinal endothelial cells to albumin. J Cell Sci.
121:1965–1972. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ando K, Ishibashi T, Ohkawara H, et al:
Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP)
in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated
endothelial cells. J Atheroscler Thromb. 18:762–773. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boutoille D, Marechal X, Pichenot M,
Chemani C, Guery B and Faure K: FITC-albumin as a marker for
assessment of endothelial permeability in mice: comparison with
125I-albumin. Exp Lung Res. 35:263–271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kajiya M, Komatsuzawa H, Papantonakis A,
et al: Aggregatibacter actinomycetemcomitans Omp29 is associated
with bacterial entry to gingival epithelial cells by F-actin
rearrangement. PLoS One. 6:e182872011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Swärd P and Rippe B: Acute and sustained
actions of hyperglycaemia on endothelial and glomerular barrier
permeability. Acta Physiol (Oxf). 204:294–307. 2012. View Article : Google Scholar
|
|
32
|
Balakumar P, Chakkarwar VA, Krishan P and
Singh M: Vascular endothelial dysfunction: a tug of war in diabetic
nephropathy? Biomed Pharmacother. 63:171–179. 2009. View Article : Google Scholar
|
|
33
|
Thomas MC: Pathogenesis and progression of
proteinuria. Contrib Nephrol. 170:48–56. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dane MJ, van den Berg BM, Avramut MC, et
al: Glomerular endothelial surface layer acts as a barrier against
albumin filtration. Am J Pathol. 82:1532–1540. 2013. View Article : Google Scholar
|
|
35
|
Stewart RJ and Marsden PA: Vascular
endothelial cell activation in models of vascular and glomerular
injury. Kidney Int Suppl. 45:S37–S44. 1994.PubMed/NCBI
|
|
36
|
Koike K, Aiboshi J, Shinozawa Y, Sekine K,
Endo T and Yamamoto Y: Correlation of glomerular permeability,
endothelial injury, and postoperative multiple organ dysfunction.
Surg Today. 34:811–816. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bates DO: Vascular endothelial growth
factors and vascular permeability. Cardiovasc Res. 87:262–271.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bogatcheva NV and Verin AD: The role of
cytoskeleton in the regulation of vascular endothelial barrier
function. Microvasc Res. 76:202–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Soulis T, Thallas V, Youssef S, et al:
Advanced glycation end products and their receptors co-localise in
rat organs susceptible to diabetic microvascular injury.
Diabetologia. 40:619–628. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hori O, Yan SD, Ogawa S, Kuwabara K,
Matsumoto M, Stern D and Schmidt AM: The receptor for advanced
glycation end-products has a central role in mediating the effects
of advanced glycation end-products on the development of vascular
disease in diabetes mellitus. Nephrol Dial Transplant. 11(Suppl 5):
13–16. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamagishi S: Role of advanced glycation
end products (AGEs) and receptor for AGEs (RAGE) in vascular damage
in diabetes. Exp Gerontol. 46:217–224. 2011. View Article : Google Scholar
|
|
42
|
Bond M, Wu YJ, Sala-Newby GB and Newby AC:
Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle
cell proliferation, and intima formation in vitro and in vivo.
Cardiovasc Res. 80:290–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Szczepanowska J: Involvement of
Rac/Cdc42/PAK pathway in cytoskeletal rearrangements. Acta Biochim
Pol. 56:225–234. 2009.PubMed/NCBI
|
|
44
|
Pai SY, Kim C and Williams DA: Rac GTPases
in human diseases. Dis Markers. 29:177–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Williams LM, Lali F, Willetts K, et al:
Rac mediates TNF-induced cytokine production via modulation of
NF-kappaB. Mol Immunol. 45:2446–2454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mondal S, Ghosh-Roy S, Loison F, et al:
PTEN negatively regulates engulfment of apoptotic cells by
modulating activation of Rac GTPase. J Immunol. 187:5783–5794.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chang F, Lemmon C, Lietha D, Eck M and
Romer L: Tyrosine phosphorylation of Rac1: a role in regulation of
cell spreading. PLoS One. 6:e285872011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jacobson JR, Dudek SM, Singleton PA,
Kolosova IA, Verin AD and Garcia JG: Endothelial cell barrier
enhancement by ATP is mediated by the small GTPase Rac and
cortactin. Am J Physiol Lung Cell Mol Physiol. 291:L289–L295. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Weed SA, Du Y and Parsons JT:
Translocation of cortactin to the cell periphery is mediated by the
small GTPase Rac1. J Cell Sci. 111:2433–2443. 1998.PubMed/NCBI
|
|
50
|
Adamson RH, Sarai RK, Altangerel A,
Thirkill TL, Clark JF and Curry FR: Sphingosine-1-phosphate
modulation of basal permeability and acute inflammatory responses
in rat venular microvessels. Cardiovasc Res. 88:344–351. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Maharjan S, Kim K, Agrawal V, et al:
Sac-1004, a novel vascular leakage blocker, enhances endothelial
barrier through the cAMP/Rac/cortactin pathway. Biochem Biophys Res
Commun. 435:420–427. 2013. View Article : Google Scholar : PubMed/NCBI
|
